Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...

Both dextromethorphan and memantine work by blocking the NMDA receptor ... If you take dextromethorphan with a drug that affects how it’s broken down, your doctor may recommend a lower dose ...

Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...

A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic ...

Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative ...

("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references ...

Amid chronic drug shortages and supply chain challenges ... we have launched key complex products such as Mesalamine, Everolimus and Memantine/Donepezil which has 180-day exclusivity.

Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products ... chronic idiopathic constipation; and Namenda, which is used in the treatment ...